Alicia Morgans, MD
No bio available.
Financial relationships
-
Attribution:SelfType of financial relationship:Consultant or Advisor (Oncology)Ineligible company:LantheusMitigation strategy:Peer reviewDate reviewed:08/25/2022
-
Attribution:SelfType of financial relationship:Consultant or Advisor (Oncology)Ineligible company:MyriadMitigation strategy:Peer reviewDate reviewed:08/25/2022
-
Attribution:SelfType of financial relationship:Consultant or Advisor (Oncology)Ineligible company:ProgenicsMitigation strategy:Peer reviewDate reviewed:08/25/2022
-
Attribution:SelfType of financial relationship:Consultant or Advisor (Specialty Not Specified)Ineligible company:Advanced Accelerator ApplicationsMitigation strategy:Peer reviewDate reviewed:08/25/2022
-
Attribution:SelfType of financial relationship:Consultant or Advisor (Specialty Not Specified)Ineligible company:SanofiMitigation strategy:Peer reviewDate reviewed:08/25/2022
-
Attribution:SelfType of financial relationship:Consultant or Advisor (Specialty Not Specified)Ineligible company:BayerMitigation strategy:Peer reviewDate reviewed:08/25/2022
-
Attribution:SelfType of financial relationship:Consultant or Advisor (Specialty Not Specified)Ineligible company:Astra ZenecaMitigation strategy:Peer reviewDate reviewed:08/25/2022
-
Attribution:SelfType of financial relationship:Consultant or Advisor (Specialty Not Specified)Ineligible company:AstellasMitigation strategy:Peer reviewDate reviewed:08/25/2022
-
Attribution:SelfType of financial relationship:Consultant or Advisor (Specialty Not Specified)Ineligible company:GenetechMitigation strategy:Peer reviewDate reviewed:08/25/2022
-
Attribution:SelfType of financial relationship:Consultant or Advisor (Specialty Not Specified)Ineligible company:GenetechMitigation strategy:Peer reviewDate reviewed:08/25/2022